Back to search

Institutional Repository of Vilnius University

DPP4 baltymo įtakos kolorektalinio vėžio ląstelių epitelinei-mezenchiminei tranzicijai ir atsparumo chemoterapiniams vaistams tyrimai /

Abstract

dc:description

Colorectal cancer is one of the most common cancer and there is no effective therapy for late stages. The situation is exacerbated by the fact that cancer cells undergo fast adaptation and become resistant to anticancer drugs, so chemotherapy completely loses its effectiveness over time with fatal consequences for patients. Therefore, one of the most important humanity tasks is to fully investigate cancer drug resistance molecular mechanisms. Our laboratory model cell lines for research of chemoresistance mechanisms are HCT-P (HCT116 parental colon cancer cell line), HCT-Oxa (HCT116 cell line, resistant to oxaliplatin) and HCT-Fu (HCT116 cell line, resistant to 5-fluoruracil). The combination of anticancer drugs oxaliplatin and 5-fluorouracil is one of the most commonly used chemotherapies for colorectal cancer. Our proteomic analysis data showed, that HCT-Oxa cell line exibited elevated DPP4 protein levels in comparison to HCT-P cell line, while HCT-Fu cell line demonstrated comparable to HCT-P cell line DPP4 levels. Also, it was shown that these cell lines have different epithelial–mesenchymal transition (EMT) statuses. Thefore, the aim of this study was to elucidate, whether DPP4 protein affects anticancer drug resistance and EMT status in HCT-P, HCT-Oxa, and HCT-Fu cell lines. To start with, proteomic analysis data were confirmed by αDPP4 western blot. Than, DPP4 coding sequence was tagged with a C-HA tag and cloned into pcDNA3 vector. After that, DPP4-HA construct was transiently expressed in HCT-P, HepG2 and HEK293T cell lines and expression was confirmed by αDPP4 and αHA western blots. Next step was to clone DPP4-HA sequence in all-in-one TET ON system lentiviral vector. Stable HCT-P iDPP4 and HCT-Oxa iDPP4 cell lines with an option of inducible DPP4 expression were created. Titration of DPP4 expression levels depending on doxycycline concentrations in these cell lines was completed. It was shown, that DPP4-HA overexpression has barely no effect on oxaliplatin and 5-fluoruracil drug resistance in HCT-P and HCT-P iDPP4 cell lines. Also, it was shown, that treatment with vildagliptin, an inhibitor of DPP4 catalytic activity, barely has no effect on resistance to anticancer drugs in HCT-P, HCT-P iDPP4, HCT-Oxa and HCT-Fu cell lines. However, treatment with vildagliptin increased E-cadherin protein levels in HCT-P cell line. Therefore, endogenous DPP4 might be a positive EMT regulator in HCT116 colorectal cancer cell line.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Černuševič, Jan,

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
lit

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Černuševič, Jan,. DPP4 baltymo įtakos kolorektalinio vėžio ląstelių epitelinei-mezenchiminei tranzicijai ir atsparumo chemoterapiniams vaistams tyrimai /. Institutional Repository of Vilnius University, 2020. https://repository.vu.lt/VU:ELABAETD193303267&prefLang=en_US